Trilogy Capital’s WisdomTree Trust WisdomTree US Quality Dividend Growth Fund DGRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,101
Closed -$536K 410
2026
Q1
$536K Buy
6,101
+636
+12% +$57.8K 0.02% 257
2025
Q4
$489K Sell
5,465
-118
-2% -$10.5K 0.02% 252
2025
Q3
$497K Buy
5,583
+270
+5% +$23.4K 0.02% 251
2025
Q2
$445K Buy
5,313
+1,769
+50% +$140K 0.02% 247
2025
Q1
$283K Sell
3,544
-224
-6% -$18.4K 0.01% 289
2024
Q4
$305K Buy
+3,768
New +$315K 0.02% 278
2022
Q1
Sell
-197,029
Closed -$13M 176
2021
Q4
$13M Buy
197,029
+15,128
+8% +$950K 0.97% 35
2021
Q3
$10.7M Buy
181,901
+17,377
+11% +$1.06M 0.81% 39
2021
Q2
$9.98M Buy
+164,524
New +$9.72M 0.73% 39

Other funds holding DGRW

Trilogy Capital's DGRW Position: Q2 2026 in Review

Trilogy Capital sold out of WisdomTree Trust WisdomTree US Quality Dividend Growth Fund (DGRW) in Q2 2026, closing a stake of 6,101 shares — an estimated $536K sold.

Trilogy Capital first reported a position in DGRW in Q2 2021 and held it in 9 quarters. The position peaked at $13M in Q4 2021. 788 funds tracked by Wall St. Rank hold DGRW as of Q2 2026.

  • Trilogy Capital reported no remaining WisdomTree Trust WisdomTree US Quality Dividend Growth Fund position as of Q2 2026 after selling out during the quarter.
  • Trilogy Capital sold 6,101 WisdomTree Trust WisdomTree US Quality Dividend Growth Fund shares in Q2 2026, an estimated $536K.
  • Trilogy Capital first reported a position in WisdomTree Trust WisdomTree US Quality Dividend Growth Fund in Q2 2021 and held it in 9 quarters.
  • Trilogy Capital's WisdomTree Trust WisdomTree US Quality Dividend Growth Fund position peaked at $13M in Q4 2021.
  • 788 funds tracked by Wall St. Rank held WisdomTree Trust WisdomTree US Quality Dividend Growth Fund as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.